As previously mentioned, novel ER-targeting radiotracers for PET are a particularly interesting imaging method not only for their use in ILC but also because this imaging modality provides valuable insights into the hormonal status of the tumour, which can guide treatment decisions, particularly in hormone-sensitive cancers [95]. The gene discussed is ESR1; the disease is neoplasm.